Elucidating the specific pharmacological mechanism of motion (MOA) of Obviously happening compounds is often challenging. Though Tarselli et al. (sixty) developed the first de novo artificial pathway to conolidine and showcased that this By natural means transpiring compound successfully suppresses responses to both chemically induced and inflammat